SCHEMBL6405324

SCHEMBL6405324

Cn1c(S)nnc1COc1ccc2ccccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.58
MAPK1 P28482 3/20 0.48
MAPT P10636 2/20 0.48
GAA P10253 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CYP3A4 P08684 1/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
RAB9A P51151 4/20 0.48
TP53 P04637 4/20 0.48
LMNA P02545 2/20 0.48
ALOX5 P09917 1/20 0.47
PKM P14618 1/20 0.45
TDP1 Q9NUW8 2/20 0.44
ALDH1A1 P00352 1/20 0.44
AGXT P21549 2/20 0.42
KDM4E B2RXH2 2/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
HTT P42858 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6408000 0.81 ALOX5 (0.49) NPC1SMN1; SMN2RAB9ATP53LMNA
SCHEMBL6410916 0.76 MAPT (0.50) MAPTGAASMN1; SMN2TP53LMNA
SCHEMBL4209355 0.76 NPC1 (0.72) NPC1MAPK1MAPTGAAL3MBTL1
SCHEMBL6402280 0.74 RAB9A (0.56) NPC1MAPTGAASMN1; SMN2RAB9A
SCHEMBL12716531 0.69 PKM (0.31) PKM
SCHEMBL10012011 0.66 TSHR (0.52) NPC1MAPTL3MBTL1CYP3A4SMN1; SMN2
SCHEMBL51460 0.66 ALOX5 (1.00) NPC1MAPK1MAPTGAAL3MBTL1
SCHEMBL12938497 0.66 ALOX5 (0.78) NPC1MAPK1MAPTCYP3A4RAB9A
SCHEMBL14112929 0.65 PKM (0.45) MAPK1MAPTSMN1; SMN2LMNAPKM
Methyl Alcohol SCHEMBL29235268 0.65 ALOX5 (0.89) NPC1MAPTCYP3A4RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT NPC1 2070/4885MAPK1 4613/4885MAPT 2111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.